Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,"GPCRs, Class A Rhodopsin-like WP455",1.7058287218120157e-08,4.60063893729323,82.28992504305278,"['CCR1', 'GPR65', 'GPR87', 'OR2H2', 'GPR4', 'GPR3', 'SSTR1', 'GPR6', 'MCHR1', 'SSTR3', 'HCRTR2', 'TRHR', 'HCRTR1', 'MC4R', 'MAS1', 'OPN1SW', 'CYSLTR2', 'GPR171', 'OR7A5', 'RHO', 'ACKR4', 'OR7C1', 'GPR18']",6.3456828451406985e-06,0,0,23
2,Apoptosis Modulation and Signaling WP1772,1.5653176615726077e-05,4.711918492011032,52.1366085774027,"['BCL2A1', 'IL1R2', 'TNFRSF10C', 'TNFRSF11B', 'TNFRSF10A', 'TNFRSF1B', 'TNFRSF10D', 'BAG3', 'CASP4', 'CASP1', 'TNFSF10', 'CYCS', 'HSPA1A']",0.00291149085052505,0,0,13
3,Complement system WP2806,3.5795914288365806e-05,4.662986124682431,47.73814485383161,"['SELP', 'FCGR3A', 'CD93', 'CFH', 'C7', 'CFI', 'ICAM2', 'PLG', 'VSIG4', 'LRP2', 'SELE', 'TLR2']",0.00443869337175736,0,0,12
4,Complement and Coagulation Cascades WP558,0.00010884726114811692,5.511743225062464,50.297770690516096,"['C1QB', 'C1QA', 'SERPINA1', 'VWF', 'CFH', 'C7', 'CFI', 'PLG', 'C1QC']",0.010122795286774873,0,0,9
5,Peptide GPCRs WP24,0.00045718180545531597,5.008015087223008,38.5137865747408,"['MC4R', 'CCR1', 'GNRHR', 'SSTR1', 'SSTR3', 'HCRTR2', 'TRHR', 'HCRTR1']",0.031233007792511164,0,0,8
6,Microglia Pathogen Phagocytosis Pathway WP3937,0.000503758190201793,5.745521004942339,43.62812070701857,"['C1QB', 'C1QA', 'FCER1G', 'NCF4', 'FCGR1A', 'SIGLEC7', 'C1QC']",0.031233007792511164,0,0,7
7,Pre-implantation embryo WP3527,0.0005913859154520674,5.571064849483301,41.40995770971633,"['EGR1', 'ZFP36', 'ARGFX', 'FOXD1', 'FOSB', 'AQP3', 'TBX3']",0.03142793722116701,0,0,7
8,Hematopoietic Stem Cell Differentiation WP2849,0.0015954745537094268,4.594110378912685,29.588754081638132,"['LEF1', 'RHOH', 'FOSB', 'IKZF1', 'CD34', 'FLI1', 'RUNX1']",0.0681059844030209,0,0,7
9,Spinal Cord Injury WP2431,0.0017418361128438643,3.081948413958576,19.579049607737566,"['SELP', 'C1QB', 'LGALS3', 'EGR1', 'NR4A1', 'ZFP36', 'VCAN', 'FCGR2A', 'CDK2', 'CXCL1', 'PDYN']",0.0681059844030209,0,0,11
10,Platelet-mediated interactions with vascular and circulating cells WP4462,0.0018308060323392716,9.516542473919523,59.98275726138422,"['SELP', 'TLR7', 'SELE', 'TLR2']",0.0681059844030209,0,0,4
11,Proximal tubule transport WP4917,0.0025861265489613336,4.175415605810993,24.87543122645057,"['SLC22A6', 'SLC3A1', 'ATP6V0A4', 'SLC5A2', 'SLC22A8', 'ABCG2', 'ATP6V1B1']",0.08745809783760147,0,0,7
12,Regulation of toll-like receptor signaling pathway WP1449,0.0035744443702747956,2.7838531700472,15.684077139758543,"['CD86', 'CISH', 'PELI3', 'CD180', 'IRF7', 'IRAK3', 'TLR7', 'SMAD6', 'TLR5', 'PIK3R5', 'TLR2']",0.10752715250396423,0,0,11
13,Complement Activation WP545,0.0037576693079342336,7.475878220140515,41.74497787364177,"['C1QB', 'C1QA', 'C7', 'C1QC']",0.10752715250396423,0,0,4
14,Kynurenine Pathway and links to Cellular Senescence WP5044,0.0046221567067975325,6.977049180327869,37.51485292068257,"['IL1R2', 'KYNU', 'KMO', 'ACMSD']",0.11266582408964354,0,0,4
15,TYROBP causal network in microglia WP3945,0.004882556504619144,3.672981878088962,19.547926615777335,"['RBM47', 'ELF4', 'HCLS1', 'SLC1A5', 'TNFRSF1B', 'RUNX3', 'C1QC']",0.11266582408964354,0,0,7
16,Vitamin D Receptor Pathway WP2877,0.004918120476528908,2.527574750830565,13.433627177003475,"['LRRC25', 'SULT1C2', 'IL1RL1', 'CEACAM1', 'COL13A1', 'CASP5', 'CDK2', 'PNOC', 'SOSTDC1', 'S100A4', 'TNFRSF11B', 'S100A8']",0.11266582408964354,0,0,12
17,Heart Development WP1591,0.00522624031102043,5.036314260452191,26.461113062915373,"['FOXC1', 'SMYD1', 'NFATC1', 'TBX2', 'FGF10']",0.11266582408964354,0,0,5
18,Selenium Micronutrient Network WP15,0.005451572133369848,3.2312769738512315,16.840934925783685,"['SERPINA3', 'KYNU', 'ALOX5AP', 'DIO3', 'PLG', 'KMO', 'SEPHS2', 'XDH']",0.11266582408964354,0,0,8
19,Allograft Rejection WP2328,0.007100135562404036,3.400054914881933,16.82225246533414,"['CD86', 'C1QB', 'C1QA', 'HLA-DRB5', 'C7', 'HLA-E', 'C1QC']",0.13901318048496322,0,0,7
20,Inflammatory Response Pathway WP453,0.007990465795665522,5.81311475409836,28.07447388326395,"['CD86', 'IL4R', 'COL1A2', 'TNFRSF1B']",0.14862266379937872,0,0,4
21,Sulfation Biotransformation Reaction WP692,0.008644449919765908,8.710310965630114,41.38127451334263,"['SULT1C2', 'SULT1B1', 'SULT4A1']",0.15313025572156752,0,0,3
22,NRF2 pathway WP2884,0.01220696546238181,2.4323951434878586,10.716521377974765,"['EGR1', 'CYP2A6', 'SERPINA1', 'SRXN1', 'HGF', 'SLC39A12', 'SLC5A2', 'SLC5A3', 'EPHA2', 'HSPA1A']",0.2020977354453694,0,0,10
23,Oxidative Damage WP3941,0.012495290094740581,3.966263621436035,17.38176756896304,"['C1QB', 'C1QA', 'CYCS', 'TNFRSF1B', 'C1QC']",0.2020977354453694,0,0,5
24,Selective expression of chemokine receptors during T-cell polarization WP4494,0.016463700168403688,6.531505728314239,26.822263863302116,"['CCR1', 'IL4R', 'IL18R1']",0.2449798585058469,0,0,3
25,ID signaling pathway WP53,0.016463700168403688,6.531505728314239,26.822263863302116,"['CDK2', 'ELK1', 'PAX2']",0.2449798585058469,0,0,3
26,Thyroxine (Thyroid Hormone) Production WP1981,0.018579856186909386,13.048202614379084,52.00592478111399,"['TRH', 'CGA']",0.2658348654434728,0,0,2
27,Nuclear Receptors Meta-Pathway WP2882,0.019380173097627684,1.8132226585016853,7.150452149915173,"['SRGN', 'EGR1', 'SERPINA1', 'SRXN1', 'HGF', 'MYOF', 'AMIGO2', 'SLC39A12', 'SLC5A2', 'SLC5A3', 'CYP2A6', 'ENC1', 'ALOX5AP', 'PDK4', 'EPHA2', 'HSPA1A', 'FKBP5']",0.26701571823398146,0,0,17
28,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.023295975530899026,5.597732055178864,21.044531799939268,"['TLR7', 'TLR5', 'TLR2']",0.30445251994515204,0,0,3
29,Toll-like Receptor Signaling related to MyD88 WP3858,0.02373420182368121,4.022446406052963,15.047320997062316,"['IRF7', 'TLR7', 'TLR5', 'TLR2']",0.30445251994515204,0,0,4
30,NAD Biosynthesis II (from tryptophan) WP2485,0.033020726801122585,8.697712418300654,29.664590447718364,"['KYNU', 'KMO']",0.40945701233392007,0,0,2
31,Amyotrophic lateral sclerosis (ALS) WP2447,0.03579974127869246,3.4852459016393444,11.605222731273276,"['CASP1', 'NEFL', 'NEFM', 'NEFH']",0.41844592044534207,0,0,4
32,Imatinib and Chronic Myeloid Leukemia WP3640,0.035995347995298244,4.609030518917878,15.322102373833319,"['SPRED2', 'FLT1', 'ABCG2']",0.41844592044534207,0,0,3
33,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.04087268053080686,4.352700490998363,13.916860538110601,"['CD86', 'IL4R', 'TLR7']",0.4403488502793627,0,0,3
34,Fatty Acid Omega Oxidation WP206,0.04143067139725187,7.454715219421102,23.7338289434734,"['CYP2A6', 'ADH1B']",0.4403488502793627,0,0,2
35,Macrophage markers WP4146,0.04143067139725187,7.454715219421102,23.7338289434734,"['CD86', 'CD163']",0.4403488502793627,0,0,2
36,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.04679077955278024,3.1678092399403877,9.700050831309891,"['CASP5', 'CASP1', 'CARD6', 'NOD2']",0.48350472204539585,0,0,4
37,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.050542631871943335,6.522467320261438,19.46916123209954,"['SOCS3', 'CHI3L1']",0.4847975304350204,0,0,2
38,Vitamin B12 metabolism WP1533,0.050825547545606975,3.0744455159112825,9.159868144512044,"['SERPINA3', 'TCN1', 'PLG', 'LRP2']",0.4847975304350204,0,0,4
39,Differentiation Pathway WP2848,0.050825547545606975,3.0744455159112825,9.159868144512044,"['HGF', 'FST', 'DKK1', 'FGF10']",0.4847975304350204,0,0,4
40,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.06029330167917564,5.7973856209150325,16.282156161922053,"['HSD11B2', 'HSD3B1']",0.5607277056163334,0,0,2
41,Apoptosis WP254,0.062172267129806794,2.242246240601504,6.228615299248741,"['CASP4', 'CASP1', 'TNFSF10', 'IRF7', 'CYCS', 'TNFRSF1B']",0.5640995944460518,0,0,6
42,Oncostatin M Signaling Pathway WP2374,0.06673659491356516,2.4206349206349205,6.552663152985063,"['SOCS3', 'EGR1', 'PRKCH', 'CDK2', 'OSMR']",0.5711258229291668,0,0,5
43,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.06984529387034927,3.4053938660784175,9.063362365795971,"['EGR2', 'RAB25', 'NEFL']",0.5711258229291668,0,0,3
44,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.070623085631026,5.217320261437909,13.827976208828982,"['SST', 'DKK1']",0.5711258229291668,0,0,2
45,EDA signaling in hair follicle development WP3930,0.070623085631026,5.217320261437909,13.827976208828982,"['SOSTDC1', 'DKK1']",0.5711258229291668,0,0,2
46,Iron metabolism in placenta WP2007,0.070623085631026,5.217320261437909,13.827976208828982,"['HEPHL1', 'HAMP']",0.5711258229291668,0,0,2
47,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.07900087989959617,2.292800967937084,5.819808187430546,"['NEFL', 'NEFM', 'ELK1', 'NEFH', 'PFN2']",0.6154148638235839,0,0,5
48,Toll-like Receptor Signaling Pathway WP75,0.07940836952562373,2.0921052631578947,5.299619599421319,"['CD86', 'IRF7', 'TLR7', 'TLR5', 'PIK3R5', 'TLR2']",0.6154148638235839,0,0,6
49,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.08342993458914445,3.132569558101473,7.780513707127416,"['GGT5', 'CYSLTR2', 'TRPA1']",0.6207187133432348,0,0,3
50,Ovarian infertility WP34,0.08342993458914445,3.132569558101473,7.780513707127416,"['EGR1', 'GJA4', 'PGR']",0.6207187133432348,0,0,3
51,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.09061353815012772,3.0118972680347476,7.232022092937299,"['IRF7', 'TLR7', 'TLR2']",0.6392823922040052,0,0,3
52,White fat cell differentiation WP4149,0.09061353815012772,3.0118972680347476,7.232022092937299,"['EGR2', 'MECOM', 'EBF1']",0.6392823922040052,0,0,3
53,Cells and molecules involved in local acute inflammatory response  WP4493,0.09279905693283945,4.347222222222222,10.334733123636408,"['SELP', 'C7']",0.6392823922040052,0,0,2
54,Nephrogenesis WP5052,0.09279905693283945,4.347222222222222,10.334733123636408,"['FOXD1', 'PAX2']",0.6392823922040052,0,0,2
55,Sleep regulation WP3591,0.09804458102535014,2.900163666121113,6.735145773687645,"['CRH', 'HCRTR2', 'HCRTR1']",0.6419055721730275,0,0,3
56,TGF-beta Receptor Signaling WP560,0.1009986135531067,2.3742175856929957,5.443246361422079,"['FST', 'LEF1', 'SMAD6', 'RUNX3']",0.6419055721730275,0,0,4
57,Tryptophan catabolism leading to NAD+ production WP4210,0.10454296843066653,4.012569130216189,9.061011514513439,"['KYNU', 'KMO']",0.6419055721730275,0,0,2
58,Fluoropyrimidine Activity WP1601,0.10571263491398125,2.796411035772738,6.283621888025584,"['CDA', 'CYP2A6', 'ABCG2']",0.6419055721730275,0,0,3
59,Prion disease pathway WP3995,0.10571263491398125,2.796411035772738,6.283621888025584,"['EBF1', 'ELK1', 'BATF']",0.6419055721730275,0,0,3
60,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.10694007251173757,2.321311475409836,5.189260863450667,"['CXCL17', 'IRF7', 'CXCL1', 'TLR7']",0.6419055721730275,0,0,4
61,"COVID-19, thrombosis and anticoagulation WP4927",0.10698426202883791,13.028548123980425,29.119763165851733,['PLG'],0.6419055721730275,0,0,1
62,Nicotine Metabolism WP1600,0.10698426202883791,13.028548123980425,29.119763165851733,['CYP2A6'],0.6419055721730275,0,0,1
63,Metapathway biotransformation Phase I and II WP702,0.10961474151412341,1.7154141643672565,3.792409176971728,"['CYP39A1', 'SULT1B1', 'SULT1C2', 'CYP26B1', 'CYP2A6', 'GLYAT', 'GAL3ST2', 'SULT4A1']",0.6472489498929193,0,0,8
64,Regulatory circuits of the STAT3 signaling pathway WP4538,0.11191156289081318,2.0411278735632186,4.470164622121326,"['SOCS3', 'DUSP2', 'PTPRC', 'IL21R', 'OSMR']",0.6504859593028516,0,0,5
65,Dopaminergic Neurogenesis WP2855,0.11666110997873473,3.7257236227824464,8.004650300933069,"['SLC18A2', 'GLI2']",0.6676605063398358,0,0,2
66,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.12567206812512655,2.1758196721311474,4.512822757248813,"['FST', 'LEF1', 'SMAD6', 'RUNX3']",0.6931837529942244,0,0,4
67,Hepatitis B infection WP4666,0.12818849497732357,1.6473584366310647,3.384091803380626,"['EGR2', 'EGR3', 'ATP6AP1', 'IRF7', 'CYCS', 'NFATC1', 'ELK1', 'TLR2']",0.6931837529942244,0,0,8
68,Blood Clotting Cascade WP272,0.1291098030482713,3.477124183006536,7.1179932727768165,"['VWF', 'PLG']",0.6931837529942244,0,0,2
69,Cancer immunotherapy by PD-1 blockade WP4585,0.1291098030482713,3.477124183006536,7.1179932727768165,"['NFATC1', 'BATF']",0.6931837529942244,0,0,2
70,Pathways Regulating Hippo Signaling WP4540,0.13043780298278418,1.8021778584392014,3.6707817784546295,"['PRKCH', 'FLT1', 'LEF1', 'CDH17', 'TEAD2', 'EPHA2']",0.6931837529942244,0,0,6
71,Genes controlling nephrogenesis WP4823,0.13853978636698733,2.446245908346972,4.835244105595689,"['FOXC1', 'FOXD1', 'PAX2']",0.7049968336591144,0,0,3
72,Apoptosis Modulation by HSP70 WP384,0.14184808044405478,3.2595996732026142,6.365993761673906,"['CYCS', 'HSPA1A']",0.7049968336591144,0,0,2
73,BMP Signaling Pathway in Eyelid Development WP3927,0.14184808044405478,3.2595996732026142,6.365993761673906,"['FOXC1', 'FGF10']",0.7049968336591144,0,0,2
74,Transcription co-factors SKI and SKIL protein partners WP4533,0.14184808044405478,3.2595996732026142,6.365993761673906,"['MERTK', 'TEAD2']",0.7049968336591144,0,0,2
75,Prader-Willi and Angelman Syndrome WP3998,0.14567325694725927,2.0474445515911284,3.944174931282593,"['PCSK1', 'MAGEL2', 'CGA', 'TYR']",0.7049968336591144,0,0,4
76,Cardiac Progenitor Differentiation WP2406,0.14723056262304057,2.37196845707484,4.544111540908898,"['ACTC1', 'THY1', 'DKK1']",0.7049968336591144,0,0,3
77,Tryptophan metabolism WP465,0.14723056262304057,2.37196845707484,4.544111540908898,"['KYNU', 'DHCR24', 'ACMSD']",0.7049968336591144,0,0,3
78,Ebola Virus Pathway on Host WP4217,0.1478219167349756,1.6481588672692462,3.150862761829376,"['SOCS3', 'HLA-DRB5', 'SCIN', 'ICAM2', 'IRF7', 'MERTK', 'HLA-E']",0.7049968336591144,0,0,7
79,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.15483754586428333,3.0676662821991543,5.722359657163015,"['EGR1', 'ELK1']",0.7199945882689176,0,0,2
80,GDNF/RET signaling axis WP4830,0.15483754586428333,3.0676662821991543,5.722359657163015,"['FOXC1', 'PAX2']",0.7199945882689176,0,0,2
81,22q11.2 copy number variation syndrome WP4657,0.17134640546705243,1.649584487534626,2.909979221951246,"['CLDN5', 'CYP26B1', 'FOXC1', 'ACTC1', 'VWF', 'FGF10']",0.7522034194738335,0,0,6
82,Steroid Biosynthesis WP496,0.17187969138306192,6.513458401305057,11.469943064793657,['HSD3B1'],0.7522034194738335,0,0,1
83,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.17187969138306192,6.513458401305057,11.469943064793657,['MAS1'],0.7522034194738335,0,0,1
84,Hedgehog Signaling Pathway WP4249,0.17428841454799843,2.173895253682488,3.7978902185389045,"['EVC2', 'LRP2', 'GLI2']",0.7522034194738335,0,0,3
85,Differentiation of white and brown adipocyte WP2895,0.181428514750456,2.7444100447196424,4.68441583403156,"['PLAC8', 'EBF3']",0.7522034194738335,0,0,2
86,Globo Sphingolipid Metabolism WP1424,0.181428514750456,2.7444100447196424,4.68441583403156,"['A4GALT', 'FUT1']",0.7522034194738335,0,0,2
87,Vitamin A and carotenoid metabolism WP716,0.1835998841680793,2.1150086256469236,3.5849320734624843,"['CYP26B1', 'RBP2', 'NPC1L1']",0.7522034194738335,0,0,3
88,Corticotropin-releasing hormone signaling pathway WP2355,0.18708665922942838,1.6951357345446016,2.8413582961550787,"['NR4A1', 'HSD3B1', 'CRH', 'FOSB', 'ELK1']",0.7522034194738335,0,0,5
89,Development of ureteric collection system WP5053,0.19303955197161704,2.0592212938237573,3.3871311050897868,"['FOXC1', 'PAX2', 'GLI2']",0.7522034194738335,0,0,3
90,Glycolysis and Gluconeogenesis WP534,0.19303955197161704,2.0592212938237573,3.3871311050897868,"['LDHC', 'PGAM1', 'ALDOB']",0.7522034194738335,0,0,3
91,Eicosanoid Synthesis WP167,0.19496490877701714,2.6070261437908497,4.262320091422896,"['ALOX5AP', 'TBXAS1']",0.7522034194738335,0,0,2
92,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.19496490877701714,2.6070261437908497,4.262320091422896,"['SRXN1', 'ABCG2']",0.7522034194738335,0,0,2
93,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.19655186357459384,1.7995477671000566,2.9275563967450777,"['PRKCH', 'NOD2', 'IFI44L', 'TLR2']",0.7522034194738335,0,0,4
94,Mesodermal commitment pathway WP2857,0.20171097163535376,1.4985145974559106,2.3990011497249126,"['FOXC1', 'LEF1', 'TBX6', 'SMAD6', 'DKK1', 'TEAD2', 'TBX3']",0.7522034194738335,0,0,7
95,Effects of nitric oxide WP1995,0.2025396750275525,5.210440456769984,8.320132849744216,['XDH'],0.7522034194738335,0,0,1
96,FTO Obesity Variant Mechanism WP3407,0.2025396750275525,5.210440456769984,8.320132849744216,['UCP1'],0.7522034194738335,0,0,1
97,Hfe effect on hepcidin production WP3924,0.2025396750275525,5.210440456769984,8.320132849744216,['HAMP'],0.7522034194738335,0,0,1
98,let-7 inhibition of ES cell reprogramming WP3299,0.2025396750275525,5.210440456769984,8.320132849744216,['EGR1'],0.7522034194738335,0,0,1
99,Hepatitis C and Hepatocellular Carcinoma WP3646,0.2025968920046695,2.006294850812036,3.2031240180755716,"['MYOF', 'LEF1', 'CD44']",0.7522034194738335,0,0,3
100,Metabolic reprogramming in colon cancer WP4290,0.2025968920046695,2.006294850812036,3.2031240180755716,"['PGAM1', 'SLC1A5', 'ALDOB']",0.7522034194738335,0,0,3
101,Glucocorticoid Receptor Pathway WP2880,0.20422727249155156,1.7689358155043067,2.809993148934747,"['SRGN', 'ENC1', 'AMIGO2', 'ALOX5AP']",0.7522034194738335,0,0,4
102,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.20656305295567082,1.63126026272578,2.5727414251761154,"['MC4R', 'NHSL1', 'UCP1', 'DIO3', 'TRH']",0.7533476048971524,0,0,5
103,Zinc homeostasis WP3529,0.20862203517905648,2.4827264239028946,3.891006085052998,"['SLC30A2', 'SLC39A12']",0.753469874627272,0,0,2
104,Oxidation by Cytochrome P450 WP43,0.2122615481561415,1.9560147299509,3.031697738407665,"['CYP39A1', 'CYP26B1', 'CYP2A6']",0.7592432299431215,0,0,3
105,TLR4 Signaling and Tolerance WP3851,0.2223724700243847,2.369726678550208,3.5626506671262894,"['IRF7', 'IRAK3']",0.7639704623957921,0,0,2
106,IL-18 signaling pathway WP4754,0.22956983812372006,1.3185372830039406,1.9402908888386778,"['SOCS3', 'NR4A1', 'ARL4D', 'SLC12A3', 'NRN1', 'COL1A2', 'CYCS', 'TNFRSF11B', 'FUT1', 'IL18R1', 'TGM2']",0.7639704623957921,0,0,11
107,Lung fibrosis WP3624,0.23187233754114028,1.8626373626373627,2.7223717757592083,"['SERPINA1', 'CYSLTR2', 'HGF']",0.7639704623957921,0,0,3
108,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.23206629637291537,4.341761827079935,6.342151253052079,['CASP1'],0.7639704623957921,0,0,1
109,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.23206629637291537,4.341761827079935,6.342151253052079,['DHCR24'],0.7639704623957921,0,0,1
110,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.23206629637291537,4.341761827079935,6.342151253052079,['CD86'],0.7639704623957921,0,0,1
111,Molybdenum cofactor (Moco) biosynthesis WP4507,0.23206629637291537,4.341761827079935,6.342151253052079,['XDH'],0.7639704623957921,0,0,1
112,Nanomaterial-induced inflammasome activation WP3890,0.23206629637291537,4.341761827079935,6.342151253052079,['CASP1'],0.7639704623957921,0,0,1
113,SARS-CoV-2 and COVID-19 Pathway WP4846,0.23206629637291537,4.341761827079935,6.342151253052079,['TLR7'],0.7639704623957921,0,0,1
114,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.23619064785779495,2.2665529980107983,3.2708988286651097,"['LEF1', 'DKK1']",0.7640254000269541,0,0,2
115,EPO Receptor Signaling WP581,0.23619064785779495,2.2665529980107983,3.2708988286651097,"['PTPRC', 'CISH']",0.7640254000269541,0,0,2
116,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2449831327897485,1.405588645292105,1.977053081176561,"['ADCYAP1', 'EGR1', 'SST', 'SSTR1', 'TAC1', 'RUNX3', 'YWHAH']",0.7856355637740211,0,0,7
117,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.2605013843036014,3.7212770915870426,5.005665102101844,['TLR2'],0.8114416646477086,0,0,1
118,Dual hijack model of Vif in HIV infection WP3300,0.2605013843036014,3.7212770915870426,5.005665102101844,['RUNX1'],0.8114416646477086,0,0,1
119,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.2639366704902493,2.084967320261438,2.7772725648958847,"['HGF', 'PIK3R5']",0.8114416646477086,0,0,2
120,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.2639366704902493,2.084967320261438,2.7772725648958847,"['CXCL1', 'GLI2']",0.8114416646477086,0,0,2
121,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.2639366704902493,2.084967320261438,2.7772725648958847,"['BCL2A1', 'SELE']",0.8114416646477086,0,0,2
122,VEGFA-VEGFR2 Signaling Pathway WP3888,0.27431571916299546,1.1881482611348384,1.5368407567024012,"['EGR1', 'FLT1', 'EGR3', 'TNFRSF10C', 'NFATC1', 'ELK1', 'DKK1', 'FUT1', 'SELE', 'APOLD1', 'NR4A1', 'TXNIP', 'DNAJB9', 'CYCS', 'DSC1', 'CLIC1', 'HSPA1A', 'EPHA2']",0.8140317266311902,0,0,18
123,IL-4 signaling pathway WP395,0.28209200246218785,1.6639621130340914,2.105780680157042,"['SOCS3', 'IL4R', 'ELK1']",0.8140317266311902,0,0,3
124,PI3K-Akt signaling pathway WP4172,0.28274840111400285,1.2213517039945414,1.5428088084382905,"['IL4R', 'FLT1', 'VWF', 'HGF', 'OSMR', 'PIK3R5', 'COL1A2', 'CDK2', 'COL6A6', 'PIK3AP1', 'EPHA2', 'TLR2', 'FGF10']",0.8140317266311902,0,0,13
125,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.2878852266949307,3.2559135399673735,4.0542420401809265,['TBX6'],0.8140317266311902,0,0,1
126,Vitamin B12 Disorders WP4271,0.2878852266949307,3.2559135399673735,4.0542420401809265,['TCN1'],0.8140317266311902,0,0,1
127,Vitamin D Metabolism WP1531,0.2878852266949307,3.2559135399673735,4.0542420401809265,['GC'],0.8140317266311902,0,0,1
128,Estrogen Receptor Pathway WP2881,0.2878852266949307,3.2559135399673735,4.0542420401809265,['PDK4'],0.8140317266311902,0,0,1
129,FOXP3 in COVID-19 WP5063,0.2878852266949307,3.2559135399673735,4.0542420401809265,['CD86'],0.8140317266311902,0,0,1
130,Irinotecan pathway WP229,0.2878852266949307,3.2559135399673735,4.0542420401809265,['ABCG2'],0.8140317266311902,0,0,1
131,PTF1A related regulatory pathway WP4147,0.2878852266949307,3.2559135399673735,4.0542420401809265,['FGF10'],0.8140317266311902,0,0,1
132,miRNAs involvement in the immune response in sepsis WP4329,0.2916890830548795,1.9302832244008714,2.378237929540686,"['IRF7', 'TLR7']",0.8140317266311902,0,0,2
133,SARS-CoV-2 mitochondrial interactions WP5038,0.2916890830548795,1.9302832244008714,2.378237929540686,"['IRF7', 'TLR7']",0.8140317266311902,0,0,2
134,Acute viral myocarditis WP4298,0.29322648217360076,1.4899297423887587,1.8278606951259522,"['CASP1', 'CYCS', 'NOD2', 'TLR5']",0.8140317266311902,0,0,4
135,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.30552083249064504,1.8612278244631186,2.2069272761777916,"['COL1A2', 'TNFRSF11B']",0.8291025897497436,0,0,2
136,Endoderm differentiation WP2853,0.3107723952851823,1.3261318019625334,1.5498429202759652,"['DUSP4', 'DUSP2', 'ONECUT1', 'LEF1', 'DKK1', 'GLI2']",0.8291025897497436,0,0,6
137,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.3142566267599835,2.8939641109298533,3.3498946828667666,['ELK1'],0.8291025897497436,0,0,1
138,Tamoxifen metabolism WP691,0.3142566267599835,2.8939641109298533,3.3498946828667666,['CYP2A6'],0.8291025897497436,0,0,1
139,Valproic acid pathway WP3871,0.3142566267599835,2.8939641109298533,3.3498946828667666,['CYP2A6'],0.8291025897497436,0,0,1
140,Dopamine metabolism WP2436,0.3142566267599835,2.8939641109298533,3.3498946828667666,['TYR'],0.8291025897497436,0,0,1
141,Gene regulatory network modelling somitogenesis  WP2854,0.3142566267599835,2.8939641109298533,3.3498946828667666,['TBX6'],0.8291025897497436,0,0,1
142,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.31930070696952323,1.7969348659003832,2.051420312839031,"['LEF1', 'GLI2']",0.8364779083990327,0,0,2
143,Circadian rhythm related genes WP3594,0.32199310774734924,1.2496195727357167,1.4161003129835488,"['PER2', 'EGR1', 'MAGEL2', 'EGR3', 'CRH', 'CARTPT', 'HCRTR2', 'HCRTR1']",0.8376324201539435,0,0,8
144,Cytosolic DNA-sensing pathway WP4655,0.33313239046417936,1.50349364220068,1.6526632135310826,"['CASP1', 'IRF7', 'POLR2K']",0.8465562514867119,0,0,3
145,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.3396529577676662,2.604404567699837,2.8123165155461947,['IKZF1'],0.8465562514867119,0,0,1
146,Osteoblast Signaling WP322,0.3396529577676662,2.604404567699837,2.8123165155461947,['TNFRSF11B'],0.8465562514867119,0,0,1
147,Role of Osx and miRNAs in tooth development WP3971,0.3396529577676662,2.604404567699837,2.8123165155461947,['DKK1'],0.8465562514867119,0,0,1
148,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.3466456524378719,1.6807927472064095,1.7807195659055106,"['FYB1', 'TEAD2']",0.8465562514867119,0,0,2
149,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3601840285975813,1.6281658496732025,1.6625855811735457,"['HGF', 'ELK1']",0.8465562514867119,0,0,2
150,Parkinson's disease pathway WP2371,0.3601840285975813,1.6281658496732025,1.6625855811735457,"['PINK1', 'CYCS']",0.8465562514867119,0,0,2
151,Serotonin and anxiety-related events WP3944,0.3641102156932094,2.3674922141480055,2.3918742276395974,['CRH'],0.8465562514867119,0,0,1
152,ACE Inhibitor Pathway WP554,0.3641102156932094,2.3674922141480055,2.3918742276395974,['MAS1'],0.8465562514867119,0,0,1
153,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.3641102156932094,2.3674922141480055,2.3918742276395974,['SMAD6'],0.8465562514867119,0,0,1
154,Cancer immunotherapy by CTLA4 blockade WP4582,0.3641102156932094,2.3674922141480055,2.3918742276395974,['CD86'],0.8465562514867119,0,0,1
155,Transcriptional cascade regulating adipogenesis WP4211,0.3641102156932094,2.3674922141480055,2.3918742276395974,['EGR2'],0.8465562514867119,0,0,1
156,LTF danger signal response pathway WP4478,0.3641102156932094,2.3674922141480055,2.3918742276395974,['TLR2'],0.8465562514867119,0,0,1
157,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.3641102156932094,2.3674922141480055,2.3918742276395974,['PGR'],0.8465562514867119,0,0,1
158,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.3641102156932094,2.3674922141480055,2.3918742276395974,['HLA-DRB5'],0.8465562514867119,0,0,1
159,Purine metabolism WP4792,0.3641102156932094,2.3674922141480055,2.3918742276395974,['XDH'],0.8465562514867119,0,0,1
160,RalA downstream regulated genes WP2290,0.3641102156932094,2.3674922141480055,2.3918742276395974,['YBX3'],0.8465562514867119,0,0,1
161,MAPK Signaling Pathway WP382,0.37176357385653397,1.1589403973509933,1.1467682560194887,"['DUSP4', 'NR4A1', 'DUSP2', 'IL1R2', 'NFATC1', 'ELK1', 'DUSP6', 'HSPA1B', 'HSPA1A', 'FGF10']",0.8579353565925145,0,0,10
162,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.3736170101289983,1.5787284610814023,1.5542961278398801,"['IFITM3', 'IFITM2']",0.8579353565925145,0,0,2
163,Nuclear receptors WP170,0.38693385674958514,1.5321991541714726,1.4548254156415183,"['NR4A1', 'PGR']",0.8635368977508373,0,0,2
164,Cysteine and methionine catabolism WP4504,0.38766306968922,2.1700652528548123,2.0563944001677195,['SQOR'],0.8635368977508373,0,0,1
165,Farnesoid X receptor pathway WP2879,0.38766306968922,2.1700652528548123,2.0563944001677195,['FKBP5'],0.8635368977508373,0,0,1
166,Ganglio Sphingolipid Metabolism WP1423,0.38766306968922,2.1700652528548123,2.0563944001677195,['FUT1'],0.8635368977508373,0,0,1
167,Osteoclast Signaling WP12,0.38766306968922,2.1700652528548123,2.0563944001677195,['TNFRSF11B'],0.8635368977508373,0,0,1
168,Hippo-Merlin Signaling Dysregulation WP4541,0.39275353358735343,1.2291260030362177,1.1487079819933264,"['FLT1', 'CDH17', 'TEAD2', 'CD44', 'EPHA2']",0.8696685386577112,0,0,5
169,Adipogenesis WP236,0.400132550279287,1.2175621134693,1.1152374763929478,"['SOCS3', 'EGR2', 'CYP26B1', 'EBF1', 'UCP1']",0.8807651402597324,0,0,5
170,Cytokines and Inflammatory Response WP530,0.41034491106633125,2.0030116702221106,1.7841971198740743,['CXCL1'],0.8827170705153102,0,0,1
171,Hedgehog Signaling Pathway Netpath WP47,0.41034491106633125,2.0030116702221106,1.7841971198740743,['GLI2'],0.8827170705153102,0,0,1
172,IL-2 signaling pathway WP49,0.4131808136510086,1.4468954248366013,1.2788674249740255,"['SOCS3', 'CISH']",0.8827170705153102,0,0,2
173,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4131808136510086,1.4468954248366013,1.2788674249740255,"['PRKCH', 'HSD3B1']",0.8827170705153102,0,0,2
174,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4241047369805019,1.2809422875694239,1.0987600568978777,"['EGR1', 'CDK2', 'CGA']",0.8827170705153102,0,0,3
175,Cori Cycle WP1946,0.432187900208504,1.8598228851083662,1.5601958051101927,['PGAM1'],0.8827170705153102,0,0,1
176,ERK Pathway in Huntington's Disease WP3853,0.432187900208504,1.8598228851083662,1.5601958051101927,['ELK1'],0.8827170705153102,0,0,1
177,Galanin receptor pathway WP4970,0.432187900208504,1.8598228851083662,1.5601958051101927,['UCP1'],0.8827170705153102,0,0,1
178,Leptin Insulin Overlap WP3935,0.432187900208504,1.8598228851083662,1.5601958051101927,['SOCS3'],0.8827170705153102,0,0,1
179,Major receptors targeted by epinephrine and norepinephrine WP4589,0.432187900208504,1.8598228851083662,1.5601958051101927,['ADCY10'],0.8827170705153102,0,0,1
180,B Cell Receptor Signaling Pathway WP23,0.43637995452171174,1.197512719050311,0.9930277940364635,"['PTPRC', 'HCLS1', 'PIK3AP1', 'ELK1']",0.8827170705153102,0,0,4
181,Nephrotic syndrome WP4758,0.4388567511499023,1.3705710354317167,1.1287779447074975,"['EMP2', 'PAX2']",0.8827170705153102,0,0,2
182,Myometrial relaxation and contraction pathways WP289,0.4430000617558212,1.1325085812356979,0.9220719177130783,"['RGS4', 'PRKCH', 'ACTC1', 'CRH', 'RXFP2', 'YWHAH']",0.8827170705153102,0,0,6
183,"GPCRs, Other WP117",0.4438097775678877,1.2401215805471124,1.007424221274174,"['GNRHR', 'OR10A2', 'GPR18']",0.8827170705153102,0,0,3
184,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.4438097775678877,1.2401215805471124,1.007424221274174,"['CASP1', 'HSPA1B', 'HSPA1A']",0.8827170705153102,0,0,3
185,Serotonin and anxiety WP3947,0.45322301201189313,1.735725938009788,1.3736031268404623,['CRH'],0.8827170705153102,0,0,1
186,Type II diabetes mellitus WP1584,0.45322301201189313,1.735725938009788,1.3736031268404623,['PIK3R5'],0.8827170705153102,0,0,1
187,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.45322301201189313,1.735725938009788,1.3736031268404623,['SYTL4'],0.8827170705153102,0,0,1
188,Glutathione metabolism WP100,0.45322301201189313,1.735725938009788,1.3736031268404623,['GGT5'],0.8827170705153102,0,0,1
189,Mammalian disorder of sexual development WP4842,0.45322301201189313,1.735725938009788,1.3736031268404623,['FST'],0.8827170705153102,0,0,1
190,MAPK pathway in congenital thyroid cancer WP4928,0.45322301201189313,1.735725938009788,1.3736031268404623,['ELK1'],0.8827170705153102,0,0,1
191,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.45322301201189313,1.735725938009788,1.3736031268404623,['LEF1'],0.8827170705153102,0,0,1
192,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4639060447951806,1.3018790849673203,0.9999384828761206,"['NEFL', 'CYCS']",0.8988179617906624,0,0,2
193,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.47348007928950886,1.6271411092985317,1.2165246280576023,['LEF1'],0.9037728247954024,0,0,1
194,miR-509-3p alteration of YAP1/ECM axis WP3967,0.47348007928950886,1.6271411092985317,1.2165246280576023,['TEAD2'],0.9037728247954024,0,0,1
195,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.4761813808061798,1.2700462298740633,0.9423189859809155,"['ACTC1', 'TEAD2']",0.9037728247954024,0,0,2
196,Prostaglandin Synthesis and Regulation WP98,0.4761813808061798,1.2700462298740633,0.9423189859809155,"['HSD11B2', 'TBXAS1']",0.9037728247954024,0,0,2
197,Notch Signaling WP268,0.4882841385653454,1.2397292250233427,0.8887095542002994,"['DTX3L', 'MFNG']",0.9145849810870914,0,0,2
198,TP53 network WP1742,0.49298783508715216,1.5313309663180117,1.0830656477875409,['TNFSF10'],0.9145849810870914,0,0,1
199,Nanomaterial induced apoptosis WP2507,0.49298783508715216,1.5313309663180117,1.0830656477875409,['CYCS'],0.9145849810870914,0,0,1
200,Nicotine Activity on Dopaminergic Neurons WP1602,0.49298783508715216,1.5313309663180117,1.0830656477875409,['SLC18A2'],0.9145849810870914,0,0,1
201,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5002102630719277,1.2108223134214926,0.8387689973010788,"['TNFSF10', 'ELK1']",0.9145849810870914,0,0,2
202,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5117739528559848,1.4461663947797716,0.9687467363982402,['ELK1'],0.9145849810870914,0,0,1
203,Folate Metabolism WP176,0.5119562346827539,1.1832293523469994,0.7921911448505892,"['SERPINA3', 'PLG']",0.9145849810870914,0,0,2
204,Leptin signaling pathway WP2034,0.5196290125954361,1.099836333878887,0.7199970328591053,"['SOCS3', 'CISH', 'ELK1']",0.9145849810870914,0,0,3
205,Prolactin Signaling Pathway WP2037,0.5196290125954361,1.099836333878887,0.7199970328591053,"['SOCS3', 'CISH', 'ELK1']",0.9145849810870914,0,0,3
206,Exercise-induced Circadian Regulation WP410,0.5235190349905703,1.1568627450980393,0.7487006158985497,"['PER2', 'CLDN5']",0.9145849810870914,0,0,2
207,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.529865085743169,1.369966514982399,0.870110750822833,['FCGR2A'],0.9145849810870914,0,0,1
208,Vitamin D in inflammatory diseases WP4482,0.529865085743169,1.369966514982399,0.870110750822833,['NFATC1'],0.9145849810870914,0,0,1
209,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.529865085743169,1.369966514982399,0.870110750822833,['DUSP6'],0.9145849810870914,0,0,1
210,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.529865085743169,1.369966514982399,0.870110750822833,['CD86'],0.9145849810870914,0,0,1
211,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5377014350724347,1.0695693114812905,0.6636162326212277,"['FRAT2', 'LEF1', 'DKK1']",0.9145849810870914,0,0,3
212,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5460853632831084,1.1074954804616883,0.6700125852561857,"['IRF7', 'ELK1']",0.9145849810870914,0,0,2
213,Synaptic Vesicle Pathway WP2267,0.5460853632831084,1.1074954804616883,0.6700125852561857,"['SLC32A1', 'SLC18A2']",0.9145849810870914,0,0,2
214,Urea cycle and metabolism of amino groups WP497,0.5472869041045593,1.3013866231647635,0.7844525737301792,['CKM'],0.9145849810870914,0,0,1
215,IL1 and megakaryocytes in obesity WP2865,0.5472869041045593,1.3013866231647635,0.7844525737301792,['TLR2'],0.9145849810870914,0,0,1
216,miRNA targets in ECM and membrane receptors WP2911,0.5472869041045593,1.3013866231647635,0.7844525737301792,['COL1A2'],0.9145849810870914,0,0,1
217,Purine metabolism and related disorders WP4224,0.5472869041045593,1.3013866231647635,0.7844525737301792,['XDH'],0.9145849810870914,0,0,1
218,Wnt signaling WP428,0.5554537796401801,1.020443587270974,0.5999900918527419,"['FRAT2', 'LEF1', 'NFATC1', 'DKK1']",0.9145849810870914,0,0,4
219,Gastrin signaling pathway WP4659,0.5629202411396361,1.0104727041222346,0.5806351257457177,"['EGR1', 'PRKCH', 'ELK1', 'CD44']",0.9145849810870914,0,0,4
220,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5640641313823404,1.2393381496154743,0.7096293168795427,['LEF1'],0.9145849810870914,0,0,1
221,"GPCRs, Class B Secretin-like WP334",0.5640641313823404,1.2393381496154743,0.7096293168795427,['GIPR'],0.9145849810870914,0,0,1
222,Hippo-Yap signaling pathway WP4537,0.5640641313823404,1.2393381496154743,0.7096293168795427,['TEAD2'],0.9145849810870914,0,0,1
223,NAD+ biosynthetic pathways WP3645,0.5640641313823404,1.2393381496154743,0.7096293168795427,['ACMSD'],0.9145849810870914,0,0,1
224,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5640641313823404,1.2393381496154743,0.7096293168795427,['BCL2A1'],0.9145849810870914,0,0,1
225,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5678939462319196,1.0621581966119782,0.6009909796839947,"['SOCS3', 'YBX3']",0.9145849810870914,0,0,2
226,Translation Factors WP107,0.5678939462319196,1.0621581966119782,0.6009909796839947,"['EIF4A2', 'EIF1AY']",0.9145849810870914,0,0,2
227,Pathogenic Escherichia coli infection WP2272,0.5678939462319196,1.0621581966119782,0.6009909796839947,"['HCLS1', 'TLR5']",0.9145849810870914,0,0,2
228,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.56811351508824,0.9815069348994128,0.5549774213992559,"['COL1A2', 'IL4R', 'FLT1', 'VWF', 'HGF', 'HIF3A', 'OSMR', 'EPHA2', 'PIK3R5', 'FGF10']",0.9145849810870914,0,0,10
229,Osteoblast differentiation WP4787,0.5703177758411575,1.0006935687263556,0.5619510535683185,"['PRKCH', 'PIK3R5', 'FGF10', 'GLI2']",0.9145849810870914,0,0,4
230,Interferon type I signaling pathways WP585,0.5785110003498282,1.0408496732026145,0.5696546501247421,"['SOCS3', 'PTPRC']",0.9145849810870914,0,0,2
231,Phosphodiesterases in neuronal function WP4222,0.5785110003498282,1.0408496732026145,0.5696546501247421,"['ADCY10', 'PDE10A']",0.9145849810870914,0,0,2
232,RANKL/RANK signaling pathway WP2018,0.5785110003498282,1.0408496732026145,0.5696546501247421,"['TNFRSF11B', 'NFATC1']",0.9145849810870914,0,0,2
233,Constitutive Androstane Receptor Pathway WP2875,0.5802205793993376,1.1829304463888477,0.6439245668694425,['CYP2A6'],0.9145849810870914,0,0,1
234,Estrogen signaling pathway WP712,0.5802205793993376,1.1829304463888477,0.6439245668694425,['ELK1'],0.9145849810870914,0,0,1
235,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5802205793993376,1.1829304463888477,0.6439245668694425,['CGA'],0.9145849810870914,0,0,1
236,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5802205793993376,1.1829304463888477,0.6439245668694425,['PLA1A'],0.9145849810870914,0,0,1
237,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5889356123979912,1.0203767781622453,0.5402266673141813,"['LEF1', 'TNFRSF11B']",0.9150803220609703,0,0,2
238,Angiogenesis WP1539,0.5957791817047497,1.1314277608341017,0.5859496707809024,['FLT1'],0.9150803220609703,0,0,1
239,Unfolded protein response WP4925,0.5957791817047497,1.1314277608341017,0.5859496707809024,['TXNIP'],0.9150803220609703,0,0,1
240,Gastric Cancer Network 1 WP2361,0.5957791817047497,1.1314277608341017,0.5859496707809024,['GATD3A'],0.9150803220609703,0,0,1
241,MTHFR deficiency WP4288,0.5957791817047497,1.1314277608341017,0.5859496707809024,['CYCS'],0.9150803220609703,0,0,1
242,Pregnane X receptor pathway WP2876,0.5957791817047497,1.1314277608341017,0.5859496707809024,['CYP2A6'],0.9150803220609703,0,0,1
243,Pathways in clear cell renal cell carcinoma WP4018,0.597754081346279,0.9755523731587561,0.5019956865831359,"['LDHC', 'FLT1', 'ALDOB']",0.9150803220609703,0,0,3
244,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6059056185984579,0.9634478996181124,0.48271731269789,"['FRAT2', 'LEF1', 'DKK1']",0.9235913562595359,0,0,3
245,Canonical and non-canonical Notch signaling WP3845,0.6107620259135641,1.0842169657422511,0.5345708749395669,['LEF1'],0.9235913562595359,0,0,1
246,Photodynamic therapy-induced unfolded protein response WP3613,0.6107620259135641,1.0842169657422511,0.5345708749395669,['DNAJB9'],0.9235913562595359,0,0,1
247,7-oxo-C and 7beta-HC pathways WP5064,0.6251903847732699,1.0407830342577489,0.48885481284901233,['HSD11B2'],0.9284885323156203,0,0,1
248,Ethanol effects on histone modifications WP3996,0.6251903847732699,1.0407830342577489,0.48885481284901233,['ADH1B'],0.9284885323156203,0,0,1
249,Gastric Cancer Network 2 WP2363,0.6251903847732699,1.0407830342577489,0.48885481284901233,['PLAC8'],0.9284885323156203,0,0,1
250,Purinergic signaling WP4900,0.6251903847732699,1.0407830342577489,0.48885481284901233,['GNAT3'],0.9284885323156203,0,0,1
251,Calcium Regulation in the Cardiac Cell WP536,0.6264801656215611,0.9286300727187426,0.43426286240019046,"['RGS4', 'GJD2', 'PRKCH', 'GJA4', 'YWHAH']",0.9284885323156203,0,0,5
252,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6381704206096978,0.9289799253034547,0.4172512538955745,"['SCIN', 'RUNX3']",0.9323118656572396,0,0,2
253,Endochondral Ossification WP474,0.6381704206096978,0.9289799253034547,0.4172512538955745,"['SCIN', 'RUNX3']",0.9323118656572396,0,0,2
254,Striated Muscle Contraction Pathway WP383,0.639084746619882,1.0006901744259005,0.44802721323834377,['ACTC1'],0.9323118656572396,0,0,1
255,Monoamine Transport WP727,0.639084746619882,1.0006901744259005,0.44802721323834377,['TNFRSF11B'],0.9323118656572396,0,0,1
256,Signal transduction through IL1R WP4496,0.6524648435902134,0.9635671560630777,0.41144126853918017,['IRAK3'],0.9371309722608471,0,0,1
257,IL17 signaling pathway WP2112,0.6524648435902134,0.9635671560630777,0.41144126853918017,['IL17RB'],0.9371309722608471,0,0,1
258,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6524648435902134,0.9635671560630777,0.41144126853918017,['PGR'],0.9371309722608471,0,0,1
259,Oxidative Stress WP408,0.6524648435902134,0.9635671560630777,0.41144126853918017,['XDH'],0.9371309722608471,0,0,1
260,Sphingolipid pathway WP1422,0.6653496800069398,0.9290957818690282,0.3785531470629665,['SERINC1'],0.9431045764028924,0,0,1
261,Cell migration and invasion through p75NTR WP4561,0.6653496800069398,0.9290957818690282,0.3785531470629665,['PARD3'],0.9431045764028924,0,0,1
262,PDGFR-beta pathway WP3972,0.6653496800069398,0.9290957818690282,0.3785531470629665,['ELK1'],0.9431045764028924,0,0,1
263,Type II interferon signaling (IFNG) WP619,0.6777575589904767,0.8970017438262924,0.3489028552153147,['SOCS3'],0.9431045764028924,0,0,1
264,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6777575589904767,0.8970017438262924,0.3489028552153147,['TBXAS1'],0.9431045764028924,0,0,1
265,Endothelin Pathways WP2197,0.6777575589904767,0.8970017438262924,0.3489028552153147,['ADCY10'],0.9431045764028924,0,0,1
266,GABA receptor Signaling WP4159,0.6777575589904767,0.8970017438262924,0.3489028552153147,['SLC32A1'],0.9431045764028924,0,0,1
267,Senescence and Autophagy in Cancer WP615,0.6812617517115925,0.8570349454146509,0.32893745362853694,"['IRF7', 'CXCL1', 'CD44']",0.9431045764028924,0,0,3
268,AGE/RAGE pathway WP2324,0.682653404171469,0.8525661630772527,0.32548248675753916,"['LGALS3', 'CYCS']",0.9431045764028924,0,0,2
269,Endometrial cancer WP4155,0.682653404171469,0.8525661630772527,0.32548248675753916,"['LEF1', 'ELK1']",0.9431045764028924,0,0,2
270,Aryl Hydrocarbon Receptor Pathway WP2873,0.6897061082921904,0.867047308319739,0.3220991463056094,['MYOF'],0.9431045764028924,0,0,1
271,Tumor suppressor activity of SMARCB1 WP4204,0.6897061082921904,0.867047308319739,0.3220991463056094,['GLI2'],0.9431045764028924,0,0,1
272,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6897061082921904,0.867047308319739,0.3220991463056094,['PLG'],0.9431045764028924,0,0,1
273,Wnt signaling pathway and pluripotency WP399,0.6949757907249545,0.8384984953275962,0.3051113797923306,"['PRKCH', 'LEF1', 'CD44']",0.9431045764028924,0,0,3
274,Focal Adhesion WP306,0.7001506230410796,0.8563295257374205,0.30524704403930525,"['FGR', 'COL1A2', 'FLT1', 'VWF', 'HGF', 'ELK1']",0.9431045764028924,0,0,6
275,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.7012123051638357,0.8390254170394148,0.2978075220512918,['NFATC1'],0.9431045764028924,0,0,1
276,Melatonin metabolism and effects WP3298,0.7012123051638357,0.8390254170394148,0.2978075220512918,['PER2'],0.9431045764028924,0,0,1
277,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7071320011772915,0.8124489379084967,0.2815443686750218,"['DKK1', 'PAX2']",0.9431045764028924,0,0,2
278,The influence of laminopathies on Wnt signaling WP4844,0.7122925003846358,0.8127548939641109,0.2757406194054603,['LEF1'],0.9431045764028924,0,0,1
279,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7122925003846358,0.8127548939641109,0.2757406194054603,['TLR7'],0.9431045764028924,0,0,1
280,MAPK Cascade WP422,0.7122925003846358,0.8127548939641109,0.2757406194054603,['ELK1'],0.9431045764028924,0,0,1
281,DNA damage response WP707,0.7149341143699346,0.7998994469582705,0.26841816854446693,"['CDK2', 'CYCS']",0.9431045764028924,0,0,2
282,MECP2 and Associated Rett Syndrome WP3584,0.7149341143699346,0.7998994469582705,0.26841816854446693,"['SST', 'FKBP5']",0.9431045764028924,0,0,2
283,p38 MAPK Signaling Pathway WP400,0.7229624412015493,0.7880765238024618,0.2556504534630211,['ELK1'],0.9475059893539333,0,0,1
284,16p11.2 proximal deletion syndrome WP4949,0.7300150930325784,0.775924300068286,0.2441756720442946,"['SPN', 'TBX6']",0.9475059893539333,0,0,2
285,miRNA regulation of DNA damage response WP1530,0.7300150930325784,0.775924300068286,0.2441756720442946,"['CDK2', 'CYCS']",0.9475059893539333,0,0,2
286,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7332372939699331,0.7648498224738509,0.23732211526228267,['BCL2A1'],0.9475059893539333,0,0,1
287,Chemokine signaling pathway WP3929,0.7356559708328974,0.7992433795712485,0.24536188342472387,"['CCR1', 'FGR', 'PARD3', 'PIK3R5']",0.9475059893539333,0,0,4
288,Oxysterols derived from cholesterol WP4545,0.7431316649219128,0.7429503612211605,0.22056862093906152,['CYP39A1'],0.9475059893539333,0,0,1
289,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7431316649219128,0.7429503612211605,0.22056862093906152,['HSD3B1'],0.9475059893539333,0,0,1
290,ESC Pluripotency Pathways WP3931,0.7511766178527804,0.7640801001251565,0.21861437897196315,"['SMAD6', 'ELK1', 'FGF10']",0.9475059893539333,0,0,3
291,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7513633064038245,0.742530345471522,0.21226416538800807,"['LEF1', 'CYCS']",0.9475059893539333,0,0,2
292,Vitamin D-sensitive calcium signaling in depression WP4698,0.7526596213350598,0.7222675367047309,0.2052266749346811,['CALB1'],0.9475059893539333,0,0,1
293,Neovascularisation processes WP4331,0.7526596213350598,0.7222675367047309,0.2052266749346811,['ACVRL1'],0.9475059893539333,0,0,1
294,DNA damage response (only ATM dependent) WP710,0.7568772758817808,0.7566141769818696,0.2107580247987324,"['MLKL', 'LEF1', 'PIK3R5']",0.9475059893539333,0,0,3
295,Ras signaling WP4223,0.7587780813846418,0.7866845797880281,0.2171610742660367,"['FLT1', 'RASAL3', 'ELK1', 'PLA1A', 'EPHA2']",0.9475059893539333,0,0,5
296,Neural Crest Cell Migration during Development WP4564,0.761834711091688,0.7027027027027027,0.19115316747216599,['PIK3R5'],0.9475059893539333,0,0,1
297,IL-5 signaling pathway WP127,0.7706699820611566,0.6841675968060444,0.17822226268118233,['ELK1'],0.9475059893539333,0,0,1
298,PDGF Pathway WP2526,0.7706699820611566,0.6841675968060444,0.17822226268118233,['ELK1'],0.9475059893539333,0,0,1
299,Breast cancer pathway WP4262,0.7709053538081355,0.7580710781380878,0.19724226415826454,"['FRAT2', 'LEF1', 'PGR', 'FGF10']",0.9475059893539333,0,0,4
300,ATM Signaling Pathway WP2516,0.7791780003394769,0.666583009160497,0.16632296660234777,['CDK2'],0.9475059893539333,0,0,1
301,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7791780003394769,0.666583009160497,0.16632296660234777,['CISH'],0.9475059893539333,0,0,1
302,Copper homeostasis WP3286,0.7791780003394769,0.666583009160497,0.16632296660234777,['XAF1'],0.9475059893539333,0,0,1
303,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7791780003394769,0.666583009160497,0.16632296660234777,['CYCS'],0.9475059893539333,0,0,1
304,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7802719125867952,0.7470692298620121,0.1853574489985663,"['EGR1', 'EGR2', 'ELK1', 'CDK5R1']",0.9475059893539333,0,0,4
305,T-cell receptor (TCR) signaling pathway WP69,0.783713504572989,0.6928104575163399,0.16884605127631894,"['FYB1', 'NFATC1']",0.9475059893539333,0,0,2
306,Aryl Hydrocarbon Receptor Netpath WP2586,0.7873708681528866,0.6498776508972267,0.15535708586517438,['CDK2'],0.9475059893539333,0,0,1
307,DNA Replication WP466,0.7873708681528866,0.6498776508972267,0.15535708586517438,['CDK2'],0.9475059893539333,0,0,1
308,IL-6 signaling pathway WP364,0.7873708681528866,0.6498776508972267,0.15535708586517438,['SOCS3'],0.9475059893539333,0,0,1
309,Neural Crest Cell Migration in Cancer WP4565,0.7873708681528866,0.6498776508972267,0.15535708586517438,['PIK3R5'],0.9475059893539333,0,0,1
310,Alzheimer's disease WP2059,0.7897222849318849,0.6836515307877536,0.1613923059384004,"['CYCS', 'CDK5R1']",0.9475059893539333,0,0,2
311,Eukaryotic Transcription Initiation WP405,0.7952602407512129,0.6339871881589941,0.14523750722584508,['POLR2K'],0.9475059893539333,0,0,1
312,ATM Signaling Network in Development and Disease  WP3878,0.8028573430446856,0.6188534141225821,0.13588674089545144,['CDK5R1'],0.9475059893539333,0,0,1
313,Integrated Cancer Pathway WP1971,0.8028573430446856,0.6188534141225821,0.13588674089545144,['CDK2'],0.9475059893539333,0,0,1
314,Interleukin-11 Signaling Pathway WP2332,0.8028573430446856,0.6188534141225821,0.13588674089545144,['SOCS3'],0.9475059893539333,0,0,1
315,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.810172985510614,0.60442353655298,0.12723568263930643,['DHCR24'],0.9475059893539333,0,0,1
316,Regulation of Microtubule Cytoskeleton WP2038,0.810172985510614,0.60442353655298,0.12723568263930643,['RHO'],0.9475059893539333,0,0,1
317,Glioblastoma signaling pathways WP2261,0.8123083479941318,0.6493055555555556,0.1349745689683274,"['PRKCH', 'CDK2']",0.9475059893539333,0,0,2
318,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8172175793308509,0.5906495625092689,0.11922255784879769,['EIF4A2'],0.9475059893539333,0,0,1
319,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8172175793308509,0.5906495625092689,0.11922255784879769,['ADCY10'],0.9475059893539333,0,0,1
320,Cell cycle WP179,0.8173354706673399,0.6771507863089732,0.13658514328477628,"['CDK2', 'CDC14A', 'YWHAH']",0.9475059893539333,0,0,3
321,Pyrimidine metabolism WP4022,0.8176059746844425,0.6412490922294843,0.1291313768992089,"['CDA', 'POLR2K']",0.9475059893539333,0,0,2
322,Histone Modifications WP2369,0.8240011512865953,0.5774877650897227,0.111792017236435,['SMYD1'],0.949004421915212,0,0,1
323,IL-3 signaling pathway WP286,0.8240011512865953,0.5774877650897227,0.111792017236435,['CD86'],0.949004421915212,0,0,1
324,Neural Crest Differentiation WP2064,0.8278012472165803,0.6257185605165761,0.11824966577003757,"['MIA', 'TBX6']",0.950438469026444,0,0,2
325,Netrin-UNC5B signaling pathway WP4747,0.830533357690277,0.5648982197318959,0.10489436020154605,['SELE'],0.9506412586485632,0,0,1
326,Insulin Signaling WP481,0.8375627010276283,0.6781099324975892,0.12020119104575326,"['SOCS3', 'EGR1', 'PRKCH', 'ELK1']",0.9557463950376618,0,0,4
327,TNF-alpha signaling pathway WP231,0.842133868753914,0.6037771697826417,0.1037387523075475,"['TNFRSF1B', 'SELE']",0.9559498683781993,0,0,2
328,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8428805291076596,0.5412928221859706,0.0925232103136509,['PTPRC'],0.9559498683781993,0,0,1
329,Wnt Signaling Pathway WP363,0.8487130756823724,0.5302127376235976,0.08697297209107957,['LEF1'],0.9596391007715579,0,0,1
330,Oxidative phosphorylation WP623,0.8543294446882053,0.5195758564437194,0.08180118786375895,['ATP6AP1'],0.9630622831030677,0,0,1
331,Ectoderm Differentiation WP2858,0.8610501941760033,0.6176057984568623,0.09239535832132273,"['STC1', 'TNFRSF11B', 'NFATC1']",0.9656422055222974,0,0,3
332,Small cell lung cancer WP4658,0.8636337915466983,0.5704230410112763,0.0836276984129612,"['CDK2', 'CYCS']",0.9656422055222974,0,0,2
333,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8649453535503943,0.4995294265277952,0.07247619955549682,['IRF7'],0.9656422055222974,0,0,1
334,Modulators of TCR signaling and T cell activation WP5072,0.869960017162801,0.49007356335990643,0.06827118054654974,['RHOH'],0.9656422055222974,0,0,1
335,Genotoxicity pathway WP4286,0.8747887722070276,0.4809679173463839,0.0643404370180398,['PCDH8'],0.9656422055222974,0,0,1
336,IL-1 signaling pathway WP195,0.8747887722070276,0.4809679173463839,0.0643404370180398,['IRAK3'],0.9656422055222974,0,0,1
337,PPAR signaling pathway WP3942,0.8747887722070276,0.4809679173463839,0.0643404370180398,['UCP1'],0.9656422055222974,0,0,1
338,MET in type 1 papillary renal cell carcinoma WP4205,0.8839158274571239,0.4637322302493591,0.057221514520311795,['HGF'],0.9728304373196749,0,0,1
339,Kit receptor signaling pathway WP304,0.8923785744186149,0.4476852112279912,0.05097559852511466,['TBX2'],0.9746742454414418,0,0,1
340,Proteasome Degradation WP183,0.8923785744186149,0.4476852112279912,0.05097559852511466,['HLA-E'],0.9746742454414418,0,0,1
341,Thermogenesis WP4321,0.8956951610014589,0.5187908496732027,0.0571474817853043,"['ADCY10', 'UCP1']",0.9746742454414418,0,0,2
342,Ciliopathies WP4803,0.8973035601490633,0.5989576423765753,0.06490368326325456,"['EVC2', 'DNAH11', 'CCDC65', 'GLI2']",0.9746742454414418,0,0,4
343,3q29 copy number variation syndrome WP4906,0.9002252909752985,0.4327079934747145,0.04548203398120851,['HAMP'],0.9746742454414418,0,0,1
344,G1 to S cell cycle control WP45,0.9039317598852081,0.4255876768379108,0.04298495471229948,['CDK2'],0.9746742454414418,0,0,1
345,p53 transcriptional gene network WP4963,0.9039317598852081,0.4255876768379108,0.04298495471229948,['TNFRSF10D'],0.9746742454414418,0,0,1
346,Male infertility WP4673,0.907565067477574,0.49871166415284063,0.048370052142752445,"['CYP26B1', 'ETV5']",0.9757635985597038,0,0,2
347,Melanoma WP4685,0.9142464835553112,0.4055617862969005,0.036360669618549446,['ELK1'],0.9783689475526262,0,0,1
348,Integrated breast cancer pathway WP1984,0.9152483702911665,0.5360347649415881,0.04747113564982734,"['CDK2', 'RHO', 'SMAD6']",0.9783689475526262,0,0,3
349,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9290391451189759,0.3760550393644939,0.02767930712703874,['LEF1'],0.9865634776416701,0,0,1
350,Head and Neck Squamous Cell Carcinoma WP4674,0.9290391451189759,0.3760550393644939,0.02767930712703874,['PIK3R5'],0.9865634776416701,0,0,1
351,Non-small cell lung cancer WP4255,0.9316766370850313,0.3706595199254253,0.026231381636745946,['CYCS'],0.9865634776416701,0,0,1
352,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9455684400990714,0.34126813771786724,0.01910043927239394,['CISH'],0.9865634776416701,0,0,1
353,DNA IR-damage and cellular response via ATR WP4016,0.949541223257909,0.3324758438950935,0.017214380313438655,['CDK2'],0.9865634776416701,0,0,1
354,Amino Acid metabolism WP3925,0.9514176847416941,0.3282466392714808,0.016347374261947045,['PDK4'],0.9865634776416701,0,0,1
355,TGF-beta Signaling Pathway WP366,0.9546316151029005,0.40780196593072926,0.01893414588347252,"['COL1A2', 'FOSB']",0.9865634776416701,0,0,2
356,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9549641632442011,0.3201015044408193,0.014750746146655034,['HGF'],0.9865634776416701,0,0,1
357,Retinoblastoma gene in cancer WP2446,0.9582521285459232,0.3123489062285029,0.013319917153614006,['CDK2'],0.9865634776416701,0,0,1
358,Androgen receptor signaling pathway WP138,0.9598051030949769,0.3086110463761361,0.01266077828166671,['ETV5'],0.9865634776416701,0,0,1
359,Pancreatic adenocarcinoma pathway WP4263,0.9598051030949769,0.3086110463761361,0.01266077828166671,['DUSP6'],0.9865634776416701,0,0,1
360,Cytoplasmic Ribosomal Proteins WP477,0.9627401457949222,0.301396107591335,0.011444535181830267,['RPS4Y1'],0.9865634776416701,0,0,1
361,ErbB signaling pathway WP673,0.964126412939012,0.29791303369522415,0.010883614918214404,['ELK1'],0.9865634776416701,0,0,1
362,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9654611807968473,0.2945091205694795,0.010351814241993822,['UCP1'],0.9865634776416701,0,0,1
363,G Protein Signaling Pathways WP35,0.9667463596191163,0.29118169987352677,0.009847507128494502,['PRKCH'],0.9865634776416701,0,0,1
364,Nonalcoholic fatty liver disease WP4396,0.9669607083516353,0.37779686083679215,0.012692998627956234,"['SOCS3', 'CYCS']",0.9865634776416701,0,0,2
365,Regulation of Actin Cytoskeleton WP51,0.9679991111269074,0.3750355214549588,0.012197696539947902,"['PIK3R5', 'FGF10']",0.9865634776416701,0,0,2
366,Integrin-mediated Cell Adhesion WP185,0.9735144390980672,0.27268824590023183,0.0073196675439473275,['RHO'],0.9887391277353154,0,0,1
367,7q11.23 copy number variation syndrome WP4932,0.9754496233302707,0.2670321723482619,0.006637555194096882,['CLDN5'],0.9887391277353154,0,0,1
368,Genes related to primary cilium development (based on CRISPR) WP4536,0.9796921464239609,0.25386239324441034,0.005208467551492479,['EVC2'],0.989487905440152,0,0,1
369,EGF/EGFR signaling pathway WP437,0.9815081642672476,0.33354417035631456,0.0062255843109363836,"['FOSB', 'ELK1']",0.989487905440152,0,0,2
370,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9908513086897188,0.21024151513945807,0.0019322872117084812,['TRIP10'],0.9962072617096632,0,0,1
371,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9957223185408115,0.18060895059263737,0.0007742447286361549,['CLDN5'],0.9969343772876935,0,0,1
372,Ciliary landscape WP4352,0.9969343772876935,0.2465209369234137,0.000756900963376321,"['NEFL', 'NEFM']",0.9969343772876935,0,0,2
